Med..Glyburide recalled
Pharmacia Recalls Three Lots of Diabetes Drug
——————————————————————————–
WASHINGTON (Reuters Health) Sept 27 - Pharmacia Corp.
has initiated a voluntary recall of three lots of its
oral diabetes drug Micronase (glyburide) due to the
presence of fungal organisms resulting from
contaminated raw material used in the formulation,
according to the US Food and Drug Administration
(FDA).
The medical literature shows that, in rare cases, the
fungi involved can cause infections if they are
inhaled or enter the body through damaged skin. The
problem can be especially severe for
immuno-compromised individuals, including diabetics.
However, because the FDA is not aware of any cases of
infection associated with swallowing the fungus, the
agency stressed that patients should continue to take
their medication until a replacement is obtained.
The recalled lot numbers are 84DWB (1.25-mg tablets),
91DYR (2.5-mg tablets) and 67FPP (5-mg tablets).